AREV
EURONEXT:AREV
AREV Life Sciences Global Corp.
- Stock
Last Close
0.09
23/07 20:00
Market Cap
2.13M
Beta: 2.94
PE Ratio
−11.93
PFCF: −13.88
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
net income | -34.02K - | -75.22K 121.15% | -84.16K 11.88% | -251.66K 199.04% | -1.02M 305.29% | -8.43M 726.21% | -3.19M 62.11% | -1.05M 67.15% | -990.31K 5.58% | -1.44M 45.82% | |
depreciation and amortization | 255 - | 255 0% | 356 39.61% | 7.20K 1,923.03% | 51.58K 616.25% | 52.47K 1.72% | 65.56K 24.95% | 148.65K 126.74% | 146.45K 1.48% | 125.59K 14.24% | |
deferred income tax | 144.44K - | 6.69M 4,528.68% | 93.44K 98.60% | 280.00K 199.65% | -808.63K 388.80% | 33.99K 104.20% | |||||
stock based compensation | 35K - | 197K 462.86% | 602.67K 205.93% | 1.06M 76.06% | 105.96K 90.01% | 455.41K 329.80% | 144.19K 68.34% | ||||
change in working capital | 5.12K - | 25.75K 403.05% | 35.22K 36.76% | 90.10K 155.84% | 154.13K 71.07% | -202.98K 231.69% | 620.10K 405.50% | 423.75K 31.66% | -369.96K 187.31% | 850.35K 329.85% | |
accounts receivables | 475 - | -6.42K - | -27.86K 333.75% | -33.92K - | -4.60K 86.43% | -2.54K 44.81% | 75.29K 3,063.01% | ||||
inventory | -22.88K - | -18.99K 17.01% | 33.92K - | -4.63K 113.65% | -19.97K 331.48% | -75.29K 276.96% | |||||
accounts payables | 152.61K - | -215.13K 240.96% | 361.25K 267.92% | 178.16K 50.68% | 148.01K 16.93% | 555.52K 275.34% | |||||
other working capital | 4.64K - | 25.75K 454.50% | 119.41K - | 48.37K 59.49% | 12.15K 74.88% | 258.85K 2,030.09% | 254.82K 1.55% | -495.46K 294.43% | 294.83K 159.51% | ||
other non cash items | 45.07K - | 8.11K - | 24.66K 204.04% | 36.31K 47.27% | 1.24M 3,311.62% | 67.00K 94.59% | 97.12K 44.97% | 5.59K 94.25% | |||
net cash provided by operating activities | -28.64K - | -4.15K 85.51% | -48.58K 1,070.67% | -111.25K 128.99% | -448.13K 302.82% | -1.25M 179.52% | -113.76K 90.92% | -23.52K 79.33% | -1.47M 6,150.76% | -284.39K 80.65% | |
investments in property plant and equipment | -3.20K - | -4.55K 42.25% | -113.03K 2,383.06% | -50K 55.76% | -215.06K 330.12% | -456.14K 112.10% | -12.04K 97.36% | -81.81K 579.61% | |||
acquisitions net | 28.52K - | 20K - | 60.21K 201.06% | ||||||||
purchases of investments | 32.65K - | ||||||||||
sales maturities of investments | 20K - | ||||||||||
other investing activites | -406.24K - | -52.65K - | |||||||||
net cash used for investing activites | -3.20K - | -4.55K 42.25% | -113.03K 2,383.06% | -427.71K 278.41% | -215.06K 49.72% | -436.14K 102.80% | 48.17K 111.05% | -81.81K 269.82% | |||
debt repayment | -68.38K - | -100K - | -52.65K 47.35% | -53.58K 1.77% | -5.43K 89.87% | ||||||
common stock issued | 255K - | 1.18M 361.57% | 250.00K - | 450K 80.00% | 665K 47.78% | 202K 69.62% | |||||
common stock repurchased | |||||||||||
dividends paid | |||||||||||
other financing activites | 51.80K - | 53.22K 2.72% | 316.98K 495.64% | 630K 98.75% | 200K 68.25% | 330.25K 65.13% | 670.99K 103.18% | 11.35K 98.31% | |||
net cash used provided by financing activities | 51.80K - | 308.22K 494.95% | 1.43M 362.53% | 630K 55.81% | 350.00K 44.44% | 727.60K 107.88% | 1.28M 76.25% | 207.93K 83.79% | |||
effect of forex changes on cash | 132 - | 122 7.58% | 35 - | 52 48.57% | |||||||
net change in cash | -28.64K - | -4.15K 85.51% | 22 100.53% | 192.42K 874,518.18% | 864.44K 349.26% | -1.05M 221.49% | 21.31K 102.03% | 267.94K 1,157.54% | -139.31K 151.99% | -158.22K 13.57% | |
cash at beginning of period | 34.49K - | 5.85K 83.04% | 1.70K 70.95% | 1.72K 1.29% | 194.14K 11,180.48% | 1.06M 445.27% | 8.37K 99.21% | 29.68K 254.44% | 297.63K 902.75% | 158.31K 46.81% | |
cash at end of period | 5.85K - | 1.70K 70.95% | 1.72K 1.29% | 194.14K 11,180.48% | 1.06M 445.27% | 8.37K 99.21% | 29.68K 254.44% | 297.63K 902.75% | 158.31K 46.81% | 94 99.94% | |
operating cash flow | -28.64K - | -4.15K 85.51% | -48.58K 1,070.67% | -111.25K 128.99% | -448.13K 302.82% | -1.25M 179.52% | -113.76K 90.92% | -23.52K 79.33% | -1.47M 6,150.76% | -284.39K 80.65% | |
capital expenditure | -3.20K - | -4.55K 42.25% | -113.03K 2,383.06% | -50K 55.76% | -215.06K 330.12% | -456.14K 112.10% | -12.04K 97.36% | -81.81K 579.61% | |||
free cash flow | -28.64K - | -4.15K 85.51% | -51.78K 1,147.78% | -115.80K 123.63% | -561.16K 384.59% | -1.30M 132.13% | -328.82K 74.76% | -479.65K 45.87% | -1.48M 208.96% | -366.20K 75.29% |
All numbers in (except ratios and percentages)